BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld
BioWorld
July 1, 2009
View Archived Issues
Ironed Out at Last: FDA Clears AMAG's Feraheme for Anemia
It was a day late - but AMAG Pharmaceuticals Inc. will hardly end up any dollars short. (BioWorld Today)
Read More
Catalyst, Wyeth Partner in $500M Deal for Hemophilia Products
Read More
Exclusivity Issue Needlessly Thwarting Biogenerics Debate
Read More
Hyperion's Series C Adds $60M for Phase III Trials of HPN-100
Read More
Troubled Cell Genesys Signs Merger Deal with BioSante
Read More
Clinic Roundup
Read More
Other News To Note
Read More